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Abstract
Background: Given the established links between an individual’s behaviors and lifestyle factors and potentially adverse health
outcomes, univariate or simple multivariate health metrics and scores have been developed to quantify general health at a given
point in time and estimate risk of negative future outcomes. However, these health metrics may be challenging for widespread
use and are unlikely to be successful at capturing the broader determinants of health in the general population. Hence, there is a
need for a multidimensional yet widely employable and accessible way to obtain a comprehensive health metric.
Objective: The objective of the study was to develop and validate a novel, easily interpretable, points-based health score
(“C-Score”) derived from metrics measurable using smartphone components and iterations thereof that utilize statistical modeling
and machine learning (ML) approaches.
Methods: A literature review was conducted to identify relevant predictor variables for inclusion in the first iteration of a
points-based model. This was followed by a prospective cohort study in a UK Biobank population for the purposes of validating
the C-Score and developing and comparatively validating variations of the score using statistical and ML models to assess the
balance between expediency and ease of interpretability and model complexity. Primary and secondary outcome measures were
discrimination of a points-based score for all-cause mortality within 10 years (Harrell c-statistic) and discrimination and calibration
of Cox proportional hazards models and ML models that incorporate C-Score values (or raw data inputs) and other predictors to
predict the risk of all-cause mortality within 10 years.
Results: The study cohort comprised 420,560 individuals. During a cohort follow-up of 4,526,452 person-years, there were
16,188 deaths from any cause (3.85%). The points-based model had good discrimination (c-statistic=0.66). There was a 31%
relative reduction in risk of all-cause mortality per decile of increasing C-Score (hazard ratio of 0.69, 95% CI 0.663-0.675). A
Cox model integrating age and C-Score had improved discrimination (8 percentage points; c-statistic=0.74) and good calibration.
ML approaches did not offer improved discrimination over statistical modeling.
Conclusions: The novel health metric (“C-Score”) has good predictive capabilities for all-cause mortality within 10 years.
Embedding the C-Score within a smartphone app may represent a useful tool for democratized, individualized health risk prediction.
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A simple Cox model using C-Score and age balances parsimony and accuracy of risk predictions and could be used to produce
absolute risk estimations for app users.
(JMIR Mhealth Uhealth 2021;9(2):e25655) doi: 10.2196/25655
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Introduction
Background
Despite the empirical establishment of strong relationships
between given behaviors and lifestyle factors and the
development of preventable diseases, individuals may struggle
to tangibly conceptualize how their day-to-day behavior affects
their long-term health outcomes. A number of mortality risk
algorithms or “health metrics” have been developed to quantify
general health at a given point in time and estimate risk of
negative future outcomes; however, few of these tools are
accessible, interpretable, actionable, and easy to calculate [1-3].
Furthermore, their degrees of validation differ [2,3]. The use of
univariate measures, while easily calculable and interpretable,
may incompletely capture the wider determinants of health,
such as psychological well-being.
BMI is often used as a quick means of estimating an individual’s
relative adiposity and infer the relative likelihood of adverse
adiposity-related outcomes [4,5]. Despite its relative ease of
calculation, BMI has numerous oft-promulgated limitations,
including issues with scalability (two people with the same body
proportions but different heights will have divergent BMIs); its
ignorance of variation in physical characteristics due to age,
sex, or ethnicity [6,7]; its inability to discern between muscle
and fat; and its variable strength of relationship to health
outcomes [8].  
Multivariable risk prediction models can be easily developed
using statistical modeling [9,10] or machine learning (ML)
[2,11,12] approaches on appropriate data sets and lend
themselves to supporting decision making across the manifold
aspects of health and disease management or prevention. Indeed,
there is a multitude of models published that seek to predict
all-cause mortality [1,2]. All-cause mortality is an easily
understandable risk trajectory into which the natural histories
of many preventable diseases converge and can be manipulated
by behavior changes. Therefore, it represents an attractive target
for a general health metric or predictive model. However, there
are hurdles to the widespread use of such predictive models
[13]. Validation of models in the data sets that they were derived
from (internal validation) and an assessment of their ability to
generalize to independent data sets—preferably in different
populations (external validation)—must be achieved prior to
widespread use [14,15]. However, even when validated, models
tend to remain the preserve of clinicians and may incorporate
mathematical analysis of data points that require invasive testing
(eg, blood tests), may be nonmodifiable by users (eg, childhood
exposures), or are not easily accessible (eg, Townsend
deprivation index).
Therefore, an unmet need in public health is the presence of
validated health metrics based on models that are not only
strongly predictive of outcomes but also accessible, have an
understandable/interpretable output, and are parsimonious.
Furthermore, should causal mechanisms be clearly established
and the metrics validated as “causal prediction models,” the
focused use of modifiable predictor variables could help
demonstrate actionable insights to guide beneficial lifestyle
changes. Given the ability of smartphones to utilize inbuilt
hardware to capture multimodal data relevant to physiological
status, we believe that a smartphone app integrating product
design and technological and risk modeling principles could
present a novel conduit for risk prediction models focusing on
well-established risk factors to enable members of the general
public to engage with their health.
Here, the authors describe the development of a novel
multivariable health metric, hereon named “C-Score”, which
seeks to mathematically integrate parameters that can be
measured digitally, are almost all modifiable, and are relevant
to various domains of health. Three formats of risk score or
model were developed: (1) a simple, easy-to-interpret, 0-100
points–based score developed by summation of published
literature regarding multiple variables across multiple
geographic locations; (2) statistical modeling using Cox
proportional hazards methods analyzing C-Score with other
predictors such as age; and (3) ML models analyzing C-Score
and the same predictor variables as used for statistical modeling.
The first was validated, and the latter two were developed and
validated using the UK Biobank [16] data.
Objective
This study sought to develop and validate forms of novel risk
models for the purposes of a general health metric suitable for
embedding into a smartphone app. Given the convergence of
multiple key risk factors on the risk of all-cause mortality, as
well as morbidity and mortality from leading noncommunicable
diseases, the target endpoint chosen for this metric was all-cause
mortality.
Methods
The study was planned and conducted in accordance with
TRIPOD guidelines [17].
Candidate Explanatory Variables for Models
A comprehensive literature review was conducted using PubMed
for candidate predictor variables for all-cause mortality. Search
terms included “all-cause mortality,” “death,” “mortality
prediction,” and “risk model.” In addition, preposited candidate
variables were searched alongside “all-cause mortality,” such
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as “smoking AND all-cause mortality” and “resting heart rate
AND all-cause mortality.”
The candidate variables that were identified from the literature
review, which was led by clinical and epidemiological acumen
regarding biological plausibility, were considered by the
authorship panel in terms of their evidence base. They were
also considered in terms of the degree to which they are
modifiable, their ability to be measured using inbuilt capabilities
of commonly available smartphones, and their contributions to
engaging user design perspectives. As the intention was to
develop an interpretable “general health metric” generated using
an explainable underlying model that would be relevant to
multiple morbidities rather than mortality alone, candidate
variables were reviewed in terms of overlap with leading causes
of morbidity and mortality.
Ultimately, eight predictor variables were selected: age, cigarette
smoking, alcohol intake, self-rated health, resting heart rate,
sleep, cognition (reaction time), and anthropometrics
(waist-to-height ratio).
Development of a Points-Based Score (C-Score) 
The first risk index (“C-Score”) attempted to formulate an
easy-to-interpret continuous score that used published evidence
from multiple countries focused chiefly on modifiable factors,
as opposed to developing a model using a single large database
from one geographic location. This approach sought to utilize
published hazard ratios or regression coefficients to weight
individual parameters, as has been done elsewhere [18,19].
Studies identified using the above search criteria were reviewed
by the authorship panel for cohort size, length of follow-up,
robustness of statistical analysis, and whether or not hazard
ratios for all-cause mortality were reported (and if these were
adjusted for age, gender, and/or other confounders).
We opted to include all important variables other than age in
the first iteration of the points-based model to ascertain the
power of purely dynamic/modifiable characteristics in a risk
index.
Hazard ratios were extracted from the studies deemed to be of
the highest quality by the authorship panel. These were used as
relative “weightings” for a points-based score. The optimal
value for each input was set as 0 (lowest risk), with increasing
numbers of points assigned for greater diversions away from
optimal risk level (these points reflected the literature-extracted
hazard ratios). The raw sum of maximal hazard ratios was
approximately 25; therefore, the values for all increments of
hazard ratios were quadrupled to make a total sum of 100.
The points-based score functions in a penalizing fashion—that
is, users “start” with 100 points, and for each health domain,
they can sequentially either lose no points (if they optimize that
data input) or lose points in accordance with the hazard ratio
associated with that level of exposure. For example, users will
lose no points for being a never-smoker but will lose more points
if they smoke more than 20 cigarettes per day than if they smoke
10 cigarettes per day. As such, the output from the score is a
continuous variable—a number between 0 and 100, where 100
is optimal. Table 1 demonstrates the maximum penalty for each
subdomain, as informed by extracted hazard ratio data [1,20-25].
Table 1. The range of points allocated to users per data input to C-Score.
Range of points allocatedDomainC-Score input metric
0-7.83Cardiovascular fitnessResting heart rate (beats per minute)
0-10.26Sleep habitsAverage hours of sleep per night
0-10.80AdiposityWaist-to-height ratio
0-31.32Surrogate for existing comorbidity or perception of ill
health
Self-rated health (ordinal scale: excellent, good, fair, poor)
0-12.96Tobacco exposure, including past smokingCigarette smoking (status and cigarettes per day)
0-19.44Alcohol intakeAlcohol consumption (units/week)
0-6.75NeurocognitionReaction time (ms)
As the C-Score does not output a percentage risk prediction, it
was only assessed for discrimination in predicting all-cause
mortality within 10 years. As is evident below, percentage
absolute risk assessments are possible if the C-Score is
incorporated as a variable in statistical modeling approaches.
App Data Collection Methods and Materials
The raw data points contributing to the C-Score calculation are
intended to be obtained using an ad hoc smartphone app (Figure
1). Data inputs for the score include manual entry (eg, age,
gender, and alcohol and tobacco consumption), image analyses
(eg, waist-to-height ratio), use of phone camera technology (eg,
for resting heart rate), and screen-based reaction time testing.
Waist-to-height ratio was calculated using camera-based
anthropometric measurements (body volume index), which
produced the following outputs: waist circumference, hip
circumference, body fat percentage, and total body volume.
Resting heart rate was collected via a camera-driven
photoplethysmogram sensor, which is able to detect the heartbeat
when participants position their finger on the camera. Reaction
time in the app is measured by asking users to hold their finger
on the screen and lift it when the screen changes color; users
are asked to repeat the test three times and the average time
across the trials is then computed.
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Figure 1. Screenshots of the C-Score mobile app. (A) List of data contributing to the C-Score. (B) Resting heart rate measurement screen. (C) Body
scan screen (for waist-to-height ratio).
Study Population
The individual-level data of the UK Biobank were utilized as
the study population for the validation of the points-based model
and the development and validation of risk models for all-cause
mortality that incorporate C-Score inputs (as more complex
variants of the initial points-based score). The entirety of the
available data set with complete data regarding C-Score inputs
was used for our analyses. Briefly, the UK Biobank represents
a prospective cohort study where over 500,000 individuals aged
40 to 69 years were recruited between 2006-2010 and followed
up thereafter [16]. Participants underwent a robust assessment
at baseline, during which multiple questionnaires were
completed, anthropometric and other measures were taken, and
blood and saliva samples were obtained. In addition to robust
phenotyping, all participants have been genotyped, 100,000 are
in the process of undergoing whole-body imaging, and 20,000
have completed repeat assessments. Participants’data are linked
to multiple other electronic databases, enabling the
ascertainment of data regarding date and cause of death. The
UK Biobank is an “open” resource accessible to any researcher
approved as bona fide by the UK Biobank Access Management
Team.
Development of De Novo Models
Whereas C-Score was validated in terms of discrimination using
the UK Biobank data, four additional model versions were both
generated and validated using data from the UK Biobank,
referred to as models 2 to 5. As the continuous “health score”
does not predict percentage risks, we used Cox regression to
form variants of models that can output such a risk prediction
and assess their discrimination and calibration. This opens the
possibility of having a user-facing score, with scope for
generating individualized percentage-style risk estimates for
multiple outcomes of interest, such as all-cause mortality.
Model 2 integrated C-Score and age, whereas model 3 integrated
the raw values for all C-Score inputs and age to assess the
amount of performance sacrificed by a predetermined weighting
system. Model 4 sought to develop “maximally complex”
statistical models with interactions to identify the maximum
attainable predictive accuracy and also included sex and
ethnicity, again to assess the balance between predictive power
and expediency of a simple, interpretable score or simple model.
These Cox models were developed to predict the risk of death
within 10 years of follow-up as a complete case analysis. As
the intended smartphone app would require completion of all
data fields to generate the health score, a complete case analysis
of UK Biobank data offered a form of evaluation that most
closely aligned to the intended use of the models. The baseline
data values (ie, obtained from the assessment center) were used
to calculate C-Scores and also participants’ baseline age for the
development of the Cox models. Individual follow-up was
defined as time elapsed from initial assessment to either death
from any cause or censoring (lost to follow-up or reached the
end of study date). The end of study date was set as February
9, 2020, which corresponded to the date of data extract
download.
Development of ML-Based Models
The approach taken for the development of model 5 was to use
supervised ML. The problem was specified as a binary classifier,
aiming to assign a label representing whether or not the patient
dies 10 years postbaseline. Two commonly used supervised ML
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classifiers were chosen, the K-nearest neighbor (KNN) classifier
and the support vector machine (SVM) classifier. As the C-Score
was conceptualized as a user-friendly, easily explainable metric,
we chose to assess KNN and SVM modeling approaches because
their mechanistic underpinnings can be relatively easily relayed
to a user, compared with, for example, a neural network or
boosting algorithm. Both these algorithms were tuned to select
the optimal hyperparameters using 10-fold cross-validation on
the training and validation sets (to maximize the area under the
receiver operating characteristic curve [AUROC]).
In the UK Biobank cohort, the number of occurrences of the
outcome of interest was relatively low (less than 5%). During
the SVM and KNN development and evaluation, it became
apparent that the outcome sparsity might have had implications
for model performance (with initial AUROCs ranging between
0.67 and 0.68 when using a 70:30 “split”). The final model was
trained by randomly undersampling the training data (in order
to achieve a 50:50 split between the two outcome variables). It
is also important to note that these two algorithms are based in
feature space, so the weighting of each feature plays a crucial
role in the determination of the classification coefficients. As
such, it is important to standardize all of the inputs; this was
performed by first subtracting the mean and subsequently
dividing by the standard deviation for each feature.
We first developed and trained a KNN algorithm to derive a
binary label determining the patient’s risk of death in the next
10 years. KNNs are a type of classification algorithm based on
the premise that similar cases (in feature space) will have similar
results. The idea is to classify each new observation based on
a metric of “nearness” to all other points and to set its label as
the most common label of the K most similar training examples.
To use the KNN algorithm, two hyperparameters need to be
specified: (1) the value of K (ie, how many training examples
will it aggregate to determine the label of the test), and (2) the
metric for defining “nearness.” For both of these parameters,
we tuned our model using 10-fold cross-validation.
The hyperparameters used for defining “nearness” are the two
most commonly used distance metrics, namely the Euclidean
distance and the Manhattan distance. The other parameter to be
tuned was the value of K—values between 5 and 500 were
tested. The optimal parameters were determined by maximizing
the AUROC using 10-fold cross-validation.
We trained an SVM classifier to optimally separate in feature
space between patients. SVMs are a category of classifiers that
aim to determine the hyperplane that optimally separates the
observations into two sets of data points. The intuitive idea
behind the SVM algorithm is to maximize the probability of
making a correct prediction by determining the boundary that
is the furthest from all of the observations.
Similar to the previous KNN model, considerations in training
were taken into account in choosing the hyperparameters. In
the case of SVMs, the parameters we chose to optimize were
the shape of the separation kernel (linear, polynomial, or radial
basis function [RBF]), the C regularization parameter, the degree
of the polynomial (only true for polynomial kernels), and the
gamma kernel coefficient (for polynomial and RBF kernels).
To optimize these parameters, we used 10-fold cross-validation
on the training data to maximize the AUROC.
Statistical Analyses and Model Validation
Continuous variables for descriptive statistics are presented as
means and standard deviations. Cox models were developed
using the entire available data set and then underwent internal
validation using bootstrapping with 200 iterations (for
discrimination and calibration). Models were tested for
proportional hazards assumptions (using log-log plots) and
inclusion of restricted cubic splines or logarithms for continuous
variables.
Discrimination refers to the ability of a prediction model to
distinguish between individuals that experience an outcome of
interest and those who do not. Suitable metrics include Harrell
c-statistic, which is equivalent to the AUROC for Cox models.
A value of 0.5 means that the model is no better than tossing a
coin, whereas a value of 1 means perfect prediction.
Calibration refers to the assessment of closeness between
predicted and observed risks. This can be assessed by plotting
the observed and predicted risks across different levels, such as
by tenth of risk. However, “binning” of risk levels is not optimal,
and other approaches include linear adaptive spline hazard
regression, which interpolates across levels of risk [26].
Therefore, we assessed calibration of the models using smoothed
calibration plots to compare predicted and observed risks, which
also incorporated bootstrapping to correct for model optimism.
Bootstrap optimism-corrected values for the c-statistic were
computed, and calibration plots were formed for models 2 to 4.
Initial data handling was performed using Stata v16.0 software
(StataCorp LLC), with the statistical analyses handled in R
statistical software, notably the rms package. For model 5,
algorithms were developed using Python, including the Pandas,
NumPy, and Scikit-learn packages; the AUROC is presented.
Ethical Approval
Access to anonymized data for the UK Biobank cohort was
granted by the UK Biobank Access Management Team
(application number 55668). Ethical approval was granted by
the national research ethics committee (REC 16/NW/0274) for
the overall UK Biobank cohort.
Results
Study Population Characteristics
In the complete case analysis, there were 420,560 individuals
with complete data, including age at baseline assessment and
all metrics included in the C-Score. There was a maximum
follow-up of 13.9 years, and the total follow-up time for the
cohort was 4,526,452 person-years. During this period, there
were 16,188 deaths (3.85% of the cohort).
Demographics for the study cohort were as follows: mean age
at baseline was 56.58 (SD 8.07) years, mean resting heart rate
was 69.84 (SD 11.68) beats/minute, mean waist-to-height ratio
was 0.54 (SD 0.075), mean weekly alcohol intake was 14.34
(SD 18.84) units, mean reaction time was 558.03 (SD 117.07)
ms, and mean sleep duration was 7.16 (SD 1.26) hours. For
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self-rated health, 68,926 (16.39%) subjects reported “excellent,”
whereas 245,171 (58.30%), 88,195 (20.97%), and 18,268
(4.34%) subjects reported “good,” “fair,” and “poor,”
respectively. There were 230,798 men (55.14%) and 188,601
women (44.86%). Regarding ethnic background, subjects were
categorized as “White” (397,763, 94.92%), “mixed” (2480,
0.59%), “Asian or Asian British” (7631, 1.82%), “Black or
Black British” (6370, 1.52%), “Chinese” (1293, 0.31%), or
“Other” (3524, 0.84%).
Regarding calculated C-Scores, the mean score for participants
was 77.25 (SD 12.96; minimum 3.34, maximum 100; Figure
2). Figure 3 displays the risk of death within 10 years according
to C-Score decile.
Figure 2. Distribution of C-Score values in the study cohort (N=420,560).
Figure 3. Probability of death within the next 10 years as a function of C-Score decile.
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The hazard ratio for per-unit increase in C-Score was 0.96 (95%
CI 0.960-0.961), suggesting a 4% relative risk reduction per
unit improvement. When analyzed in terms of C-Score decile
(ie, 10-point brackets of C-Scores), the hazard ratio was 0.69
(95% CI 0.663-0.675), implying a 31% relative risk reduction
of all-cause mortality per decile improvement in C-Score.
Regarding discrimination, the c-statistic was 0.66.
Model 2
Inclusion of (log)age and C-Score in a Cox model yielded a
c-statistic of 0.74 (ie, an increase in discrimination capability
of 8 percentage points). The model appeared well-calibrated
(Figure 4). Although age is clearly a major predictor of all-cause
mortality, the Cox model demonstrated that on the inclusion of
age and C-Score, there were significant roles for both: hazard
ratio per year increase in age was 1.09 (95% CI 1.091-1.096)
and per 10-unit increase in C-Score was 0.67 (95% CI
0.668-0.681). Table 2 demonstrates the coefficients for all Cox
models developed.
Figure 4. Calibration plots of predicted versus observed probabilities of all-cause mortality within 10 years for models 2, 3, and 4. The ticks across the
upper plot border represent the distribution of predicted risks in the study cohort population. The black line displays apparent calibration and the blue
line displays the bias-corrected calibration.
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Table 2. Coefficients from Cox proportional hazards models either examining C-Score alone or alongside additional parameters/interactions or raw
data inputs (model 3).
Discrimination (c-statistic)aCoefficient (P value)Model and predictor variables












0.0685 (<.001)Cigarettes smoked per day
0.0008 (<.001)Reaction time
1.1679 (<.001)Waist-to-height ratio
0.0077 (<.001)Weekly alcohol units














–0.0094 (.04)Asian/Asian British ethnicity




aFor reference in terms of discrimination, a Cox model using simply the C-Score as the sole variate was fitted to demonstrate the scope for incremental
gains in accuracy. For models 3 and 4, the coefficients for the “excellent” self-rated health and White ethnicity are the reference categories, and therefore
their coefficients equal 0.
bModel 4 is presented prior to backward selection.
cDenotes interaction terms.
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Using the raw data inputs rather than a preassigned “weighting”
plus age yielded a c-statistic of 0.74; therefore, there was no
significant improvement in discrimination with a more complex
model. The model was also well-calibrated (Figure 4).
Model 4
We also developed a “full model” that included C-Score, age,
ethnicity, and sex, as well as interactions between C-Score and
the latter three variables. We performed backward elimination
to identify the strongest possible performing model via
bootstrapping with 200 iterations; selection was based on the
Akaike information criterion with a P value of 0.01. Herein,
the final model that retained C-Score, sex, age, an interaction
between C-Score and ethnicity, and an interaction between
C-Score and age had an optimism-corrected c-statistic of 0.74
(ie, no improvement with a more complex model).
Model 5
Both of the ML algorithms, KNN and SVM, were applied to a
test cohort (n=125,966) in order to predict risk of death in the
next 10 years. For the KNN, following 10-fold cross-validation
for the tuning of the hyperparameters (we opted to use K=100
and the Manhattan distance metric), the c-statistic on the test
data was 0.72. Similar to the KNN algorithm, we tuned the
SVM using 10-fold cross-validation on randomly under-sampled
training data. This led us to choose C=100, gamma=0.001, and
kernel shape as an RBF as the optimal hyperparameters.
Discussion
Principal Findings
Risk prediction models have significant potential for assessing
the risk of protean events of interest. However, these models
are limited almost exclusively to clinical use, and widely
used/easily accessible health metrics, such as BMI, have
limitations. Extant multivariable prediction models for all-cause
mortality are typically poorly accessible to members of the
public and risk limited engagement due to perceived
nonmodifiability of covariates or limited ability to understand
the mechanisms by which covariates may predict outcomes.
Therefore, for the purposes of this initiative, we opted to migrate
away from univariate assessments toward a novel, multivariable
health metric that is focused on characteristics that span multiple
domains of health, is accessible, and can be used by anybody
with a smartphone. Our results demonstrate the value of an
easy-to-interpret points-based score to infer all-cause mortality
risk and mandate consideration of this smartphone-based health
index in the prediction of multiple other diseases or conditions.
Our results also suggest that a simple Cox model including
C-Score and age may provide accurate absolute risk predictions
for public health initiatives, such as promoting public
understanding of individual health risk or raising awareness of
the effects of behaviors on health. Lastly, the results are
interesting regarding the power of statistical modeling
approaches relative to ML approaches using the same data.
All-cause mortality was selected as a first end point for
validation purposes given its ease of comprehension and its
close links to multiple modifiable behaviors and/or it often being
a consequence of preventable disease. This is an end point that
has been robustly examined in the UK Biobank by two other
key studies. A study by Weng et al [2] utilized the UK Biobank
to derive epidemiological models (ie, Cox) and ML models (ie,
random forests and neural networks) to predict premature
mortality using a preselected panel of 60 candidate baseline
predictor variables encompassing aspects such as
sociodemographics, educational attainment, behavior, nutritional
intake, lifestyle factors, medication use, and clinical history. In
standard Cox modeling, the final included variables were gender;
log(age); educational qualifications; ethnicity; previous
diagnoses of cancer, coronary heart disease, type 2 diabetes, or
chronic obstructive pulmonary disease; smoking history; blood
pressure; Townsend deprivation index; and BMI. Variables
included in random forests modeling included BMI, forced
expiratory volume in the first second of expiration, waist
circumference, blood pressure parameters, skin tone, and age.
On identifying the optimal neural network parameters using
grid-search from 10-fold cross-validation, top risk factor
variables included smoking status, age, prior cancer diagnosis,
prescription of digoxin, residential air pollution, and Townsend
deprivation index. The discrimination of the fully adjusted Cox,
random forests, and neural network models were 0.751 (95%
CI 0.748-0.767), 0.783 (95% CI 0.776-0.791), and 0.79 (95%
CI 0.783-0.797), respectively [10]. While these AUROC values
are significantly but marginally higher than those reported with
our intended app-based model, they included variables that are,
for the most part, nonmodifiable and do not offer clear scope
for use by members of the public to not only compute their risk
but also be able to act on various components to reduce risk.
Ganna and Ingelsson [1] used the UK Biobank cohort to identify
predictors of 5-year all-cause mortality and six cause-specific
mortality categories from 655 measurements of demographic
variables, the results of which were interestingly packaged as
part of an interactive website named Ubble. Ultimately, for
all-cause mortality within 5 years, 13 predictors for men and
11 for women in a Cox model achieved discrimination of 0.8
(95% CI 0.77-0.83) and 0.79 (95% CI 0.76-0.83), respectively.
Again, although these models attained a significantly but slightly
higher discrimination than our model, the majority of parameters
included are minimally modifiable (in retrospect, number of
children given birth to), have an effect on mortality that is
difficult to explain (number of people in the household, numbers
of cars or vans owned/used by the household, relationships of
people lived with), and emphasize existing health conditions
(known diabetic, previous cancer) [1]. While our study did not
validate the C-Score as a “causal prediction model,” where
coefficients have a direct causal interpretation, such further
work is underway, and the inclusion of modifiable factors known
to have causal implications on health outcomes is encouraging
in this regard.
In the era of “big data,” a resurgence in the popularity of
artificial intelligence and more specifically ML has been seen
across a wide array of fields including health care. These novel
methodologies have led to some notable results in prediction
and diagnostics and so have become a commonly examined
tool in medical research. It is, however, important to note that
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ML techniques do not always lead to better results than
“classical” statistical methods. Indeed, the results that we
observed using two very popular and widely used algorithms,
namely KNN and SVM, were comparatively similar or even
lower than the results observed using a traditional
epidemiological/statistical modeling strategy. ML methodologies
rely on the artificial generation of knowledge using
machine-guided computational methods instead of
human-guided data analysis in order to find a best fit in the data.
There are some very strong cases for their use, especially when
dealing with wide and complex data sets with multifactorial
causation and complex and potentially nonintuitive interactions.
However, in this study, we showed that ML is not always the
answer and that initial development of an algorithm with few
metrics and careful consideration of the input by those with
scientific/clinical acumen can yield better results.
Strengths and Limitations
Our work has some strengths and also limitations. Strengths
include the use of the UK Biobank, which provided a
contemporary, richly phenotyped cohort with linkages to
national registries that minimized loss to follow-up,
prospectively evaluated risk factors, and enabled accurate
ascertainment of outcomes of interest. Another strength was
our cognizance of the target users of the app that the model was
intended for, which drove us to focus on modifiable risk
variables where possible—we were content with sacrificing a
small percentage of discriminatory capability without needing
to “penalize” intended users for having pre-existing conditions
or a certain educational level, or living in areas of heavy air
pollution.
Possible limitations of our work include the use of a complete
case analysis, which may have introduced bias, and the use of
“human intelligence” to prune the possible list of candidate
predictor variables, which could have limited the scope for ML
to perform optimally. As the overwhelming majority of missing
data for the included variables were due to participants “not
knowing” the answer or refusing to answer, we considered this
to replicate the target end situation, where people will be using
the health index or model in an app. We mitigated bias to the
best of our abilities throughout the rest of the methodology for
the statistical modeling where possible—for example, we used
the entire data set for Cox modeling and bootstrapping for
validation rather than randomly splitting the data into
development and validation sets, which is inefficient and
inadvisable [10]. The fact that ML methods did not deliver
significant improvements in discrimination is not a formal
comparative assessment of statistics versus ML. Indeed, ML is
likely best reserved for situations other than trying to optimize
the weighting of a small number of variables that humans have
preselected, or for situations in which model explainability is
less crucial. The validation schemas were different between the
approaches, with resampling validation used in statistical
modeling and a train-test split used to tune hyperparameters
and then assess performance of the ML classifiers. Using the
same cross-validation for both hyperparameter tuning and
performance assessment on the entire data set is inherently
optimistically biased, and while nested cross-validation may be
one approach to using all of the data for training and validation,
we were unable to do it because of computational limitations.
There were also the limitations of data availability and potential
selection bias concerning the participants of the UK Biobank.
In terms of data availability, the reaction time used at the UK
Biobank baseline assessments (2006-2010) was not exactly the
same as the reaction test developed for the app: results from a
study using the NHANES cohort [23] were used to develop the
initial score and inform the reaction time test in the app.
However, because the underlying way in which points are
allocated for reaction time are based on the relative distribution
of time measurements, applying exactly the same cutoff
principles (based on standard deviations from the mean) was a
pragmatic and suitable way to validate the C-Score in a cohort
with a different measurement mechanism. In terms of UK
Biobank participants, they tend to be slightly healthier than the
general population at large [16,27]. Furthermore, the UK
Biobank only recruited individuals between the ages of 40 and
69 years who were generally more affluent and more likely to
be of White ethnicity than the general population. Use of the
C-Score outside the UK population and in different age groups
should follow validation in appropriate local data sets with
cognizance of the need for performance evaluation in different
ethnic groups, work on which is underway.
Conclusion
In conclusion, we believe that the “general health metric”
reported here not only compares well to other work despite
using fewer variables but offers several advantages from a
population-use perspective, as it offers a holistic review of
multiple aspects of health and focuses for the most part on
modifiable characteristics that could in time be targets for
risk-reducing interventions pending further model evaluation.
Our proclivity was not to produce the most powerfully predictive
models possible using a prospective data set but rather to
develop and validate models that are rational, understandable,
and could be engaging within a smartphone app. Given the
strong association of many of the included variables on other
diseases (and not just all-cause mortality), we believe that a
points-based score may be powerful in making inferences
regarding current and future health in terms of individual
conditions. Even more powerful could be simple statistical
models incorporating C-Score and age for each clinical end
point of interest. Further work is already underway within our
group to assess the capabilities of C-Score and variations thereof
across a panel of conditions of interest, as is the embedding of
this score system into a mobile app.
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